M. Lodovici et al., EFFECTS OF GM1 GANGLIOSIDE ON CARDIAC-FUNCTION FOLLOWING EXPERIMENTALHYPOXIA-REOXYGENATION, European journal of pharmacology, 243(3), 1993, pp. 255-263
Rat hearts made hypoxic for 20 min by perfusion with 95% N2/5% CO2 and
reoxygenated for 20 min in a Langerdorff apparatus showed a dose-depe
ndent reduction of lactate dehydrogenase release when incubated with g
anglioside GM1 (0.1-10 muM). The decline of contractile force during h
ypoxia was also reduced dose dependently in the presence of GM1. Simil
ar effects were observed in hearts obtained from animals treated i.p.
with 40 mg/kg GM1 for 14 days. The levels of Na+,K+-ATPase in ventricu
lar tissue were also reduced after hypoxia-reoxygenation and the reduc
tion was prevented in hearts from GM1-treated animals. GM1 (1-30 muM)
reduced the functional response to field stimulation of adrenergic ner
ve terminals in isolated atria. Rat atria made hypoxic in glucose-free
media maintained normal stores of tissue noradrenaline in the presenc
e of 1 muM GM1. In the rabbit, GM1 (40 mg/ kg i.p. for 4 days) reduced
the alterations of the ST segment of the ECG during acute occlusion o
f the left descending and circumflex coronaries artery. In conclusion,
ganglioside GM1 reduces some effects of hypoxia-reoxygenation in the
heart, through still unknown mechanisms.